<i>E. coli</i>-Produced Monophosphoryl Lipid a Significantly Enhances Protective Immunity of Pandemic H1N1 Vaccine

<i>E. coli</i>-Produced Monophosphoryl Lipid a Significantly Enhances Protective Immunity of Pandemic H1N1 Vaccine

Emerging influenza viruses pose an extreme global risk to human health, resulting in an urgent need for effective vaccination against influenza infection. Adjuvants are vital components that can improve vaccine efficacy, yet only a few adjuvants have been licensed in human vaccines. Here, we investi...

Full description

Bibliographic Details
Main Authors: Quyen Thi Nguyen, Eunjin Kim, Jihyun Yang, Chankyu Lee, Da Hui Ha, Choon Geun Lee, Ye Ram Lee, Haryoung Poo
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Vaccines
Subjects:
adjuvant
vaccine efficacy
influenza virus
monophosphoryl lipid A
antibody production
cytotoxic T lymphocyte
Online Access:https://www.mdpi.com/2076-393X/8/2/306

Internet

https://www.mdpi.com/2076-393X/8/2/306

Similar Items